Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 312 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Faecalibacteriumprausnitzii Is Associated With Clinical Response to Immune Checkpoint Inhibitors in Patients With Advanced Gastric Adenocarcinoma: Results of Microbiota Analysis of PRODIGE 59-FFCD 1707-DURIGAST Trial.
Bredon M, Le Malicot K, Louvet C, Evesque L, Gonzalez D, Tougeron D, Sokol H
Gastroenterology, S0016-5085(24)05594-X, 23 Oct 2024
Cited by: 0 articles | PMID: 39454892
Add to export list
Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma
Tougeron D, Louvet C, Desrame J, Evesque L, Angelergues A, Aurelien C, Breysacher G, Zaanan A, Etchepare N, Mabro M, Kaluzinski L, Petorin C, Chibaudel B, Aparicio T, Bodere A, Rinaldi Y, Malicot kL, Emile J, Lepage C, [...] LAURENT-PUIG P
Research Square, 18 Sep 2024
Cited by: 0 articles | PPR: PPR911310
Add to export list Preprint v1
The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research.
Moniot A, Schneider C, Chardin L, Yaniz-Galende E, Genestie C, Etiennot M, Henry A, Drelon C, Le Formal A, Langlois B, Venat L, Louvet C, Favier L, Lortholary A, Berton-Rigaud D, Dohollou N, Desauw C, Fabbro M, Malaurie E, [...] Dedieu S
Mol Cancer, 23(1):166, 14 Aug 2024
Cited by: 0 articles | PMID: 39138571 | PMCID: PMC11323699
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study of the PANACHE01-PRODIGE48 Trial.
Pinson J, Henriques J, Beaussire L, Sarafan-Vasseur N, Sa Cunha A, Bachet JB, Vernerey D, Di Fiore F, Schwarz L, PANACHE01-PRODIGE48 group
Ann Surg, 280(5):734-744, 05 Aug 2024
Cited by: 0 articles | PMID: 39101207
Add to export list
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial.
Conroy T, Castan F, Etienne PL, Rio E, Mesgouez-Nebout N, Evesque L, Vendrely V, Artignan X, Bouché O, Gargot D, Boige V, Bonichon-Lamichhane N, Louvet C, Morand C, de la Fouchardière C, Boilève A, Delaye M, Gourgou S, Pezzella V, Borg C
Ann Oncol, 35(10):873-881, 08 Jul 2024
Cited by: 22 articles | PMID: 38986769
Add to export list
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial.
Tougeron D, Dahan L, Evesque L, Le Malicot K, El Hajbi F, Aparicio T, Bouché O, Bonichon Lamichhane N, Chibaudel B, Angelergues A, Bodere A, Phelip JM, Mabro M, Kaluzinski L, Petorin C, Breysacher G, Rinaldi Y, Zaanan A, Smith D, [...] PRODIGE 59-FFCD 1707-DURIGAST Investigators/Collaborators
JAMA Oncol, 10(6):709-717, 01 Jun 2024
Cited by: 1 article | PMID: 38573643 | PMCID: PMC11190792
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Debulking hepatectomy for colorectal liver metastasis: Analysis of risk factors for progression free survival.
Mazzotta AD, Usdin N, Samer D, Tribillon E, Gayet B, Fuks D, Louvet C, Soubrane O
Surg Oncol, 55:102056, 12 Mar 2024
Cited by: 0 articles | PMID: 38531729
Add to export list
Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT).
Roth GS, Verlingue L, Sarabi M, Blanc JF, Boleslawski E, Boudjema K, Bretagne-Bignon AL, Camus-Duboc M, Coriat R, Créhange G, De Baere T, de la Fouchardière C, Dromain C, Edeline J, Gelli M, Guiu B, Horn S, Laurent-Croise V, Lepage C, [...] Malka D
Eur J Cancer, 202:114000, 13 Mar 2024
Cited by: 3 articles | PMID: 38493667
Add to export list Review
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer.
de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A
J Clin Oncol, 41(33):5080-5089, 01 Nov 2023
Cited by: 7 articles | PMID: 37967516
Add to export list
Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer.
Rasola C, Laurent-Puig P, André T, Falcoz A, Lepage C, Aparicio T, Bouché O, Lievre A, Mineur L, Bennouna J, Louvet C, Bachet JB, Borg C, Vernerey D, Lonardi S, Taieb J
Eur J Cancer, 194:113321, 09 Sep 2023
Cited by: 2 articles | PMID: 37797388
Add to export list
The estimand framework had implications in time to patient-reported outcomes deterioration analyses in cancer clinical trials.
Cottone F, Efficace F, Cella D, Aaronson NK, Giesinger JM, Bachet JB, Louvet C, Charton E, Collins GS, Anota A
J Clin Epidemiol, 162:118-126, 25 Aug 2023
Cited by: 1 article | PMID: 37634702
Add to export list
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study.
Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A
J Clin Oncol, 41(19):3469-3477, 01 Jul 2023
Cited by: 2 articles | PMID: 37379692
Add to export list
Single-cell mRNA-regulation analysis reveals cell type-specific mechanisms of type 2 diabetes
Martínez-López J, Lindqvist A, Lopez-Pascual A, Chen P, Shcherbina L, Chriett S, Skene N, Prasad R, Lancien M, Johnson P, Eliasson P, Louvet C, Muñoz-Manchado A, Sandberg R, Hjerling-Leffler J, Wierup N
bioRxiv, 24 Mar 2023
Cited by: 0 articles | PPR: PPR635692
Add to export list Preprint
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Ferron G, De Rauglaudre G, Becourt S, Delanoy N, Joly F, Lortholary A, You B, Bouchaert P, Malaurie E, Gouy S, Kaminsky MC, Meunier J, Alexandre J, Berton D, Dohollou N, Dubot C, Floquet A, Favier L, Venat-Bouvet L, [...] Pujade-Lauraine E
Gynecol Oncol, 170:186-194, 25 Jan 2023
Cited by: 7 articles | PMID: 36706645
Add to export list
CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy.
Drouin M, Saenz J, Gauttier V, Evrard B, Teppaz G, Pengam S, Mary C, Desselle A, Thepenier V, Wilhelm E, Merieau E, Ligeron C, Girault I, Lopez MD, Fourgeux C, Sinha D, Baccelli I, Moreau A, Louvet C, [...] Chiffoleau E
Sci Adv, 8(46):eabo7621, 18 Nov 2022
Cited by: 7 articles | PMID: 36399563 | PMCID: PMC9674301
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
Conroy T, Castan F, Lopez A, Turpin A, Ben Abdelghani M, Wei AC, Mitry E, Biagi JJ, Evesque L, Artru P, Lecomte T, Assenat E, Bauguion L, Ychou M, Bouché O, Monard L, Lambert A, Hammel P, Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group
JAMA Oncol, 8(11):1571-1578, 01 Nov 2022
Cited by: 80 articles | PMID: 36048453 | PMCID: PMC9437831
Add to export list Free full text in Europe PMC
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study.
André T, Tougeron D, Piessen G, de la Fouchardière C, Louvet C, Adenis A, Jary M, Tournigand C, Aparicio T, Desrame J, Lièvre A, Garcia-Larnicol ML, Pudlarz T, Cohen R, Memmi S, Vernerey D, Henriques J, Lefevre JH, Svrcek M
J Clin Oncol, 41(2):255-265, 15 Aug 2022
Cited by: 107 articles | PMID: 35969830 | PMCID: PMC9839243
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Impact of mismatch repair deficiency on tumour regression grade after neoadjuvant chemotherapy in localized gastroesophageal adenocarcinoma.
Heran M, Renaud F, Louvet C, Piessen G, Voron T, Lefèvre M, Dubreuil O, André T, Svrcek M, Cohen R
Dig Liver Dis, 55(2):276-282, 29 Jun 2022
Cited by: 2 articles | PMID: 35780065
Add to export list
Impact of trough concentrations of regorafenib and its major metabolites M-2 and M-5 on overall survival of chemorefractory metastatic colorectal cancer patients: Results from a multicentre GERCOR TEXCAN phase II study.
Rousseau B, Boukerma AK, Henriques J, Cohen R, Lucidarme O, Borg C, Tournigand C, Kim S, Bachet JB, Mazard T, Louvet C, Chibaudel B, Vernerey D, Andre T, Hulin A
Eur J Cancer, 168:99-107, 27 Apr 2022
Cited by: 4 articles | PMID: 35489233 | PMCID: PMC10492638
Add to export list Free full text in Europe PMC
SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.
Boisteau E, François E, Aparicio T, Le Malicot K, Boulahssass R, Lecomte T, Laurent-Puig P, Guiu B, Paillaud E, Galais MP, Lopez-Trabada Ataz D, Tougeron D, Dourthe LM, Guimbaud R, Samalin E, Moreau M, Louvet C, Lepage C, Lièvre A
Dig Liver Dis, 54(6):747-754, 26 Mar 2022
Cited by: 0 articles | PMID: 35351371
Add to export list
Prognostic role of infracentimetric colorectal liver metastases.
Frosio F, Cervantes B, Nassar A, Faermark N, Sanou Y, Bonnet S, Lefevre M, Louvet C, Gayet B, Fuks D
Langenbecks Arch Surg, 407(5):1971-1980, 26 Mar 2022
Cited by: 0 articles | PMID: 35347398
Add to export list
Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instability.
Boyer C, Sefrioui D, Cohen R, Chautard R, Perrier M, Lebrun H, Goujon G, Hautefeuille V, Dior M, Walter T, Mary F, Manfredi S, Caroli-Bosc FX, Cervantes B, Coriat R, Deluche E, Zaanan A, Olivier R, Bouché O, [...] Tougeron D
Dig Liver Dis, 55(1):123-130, 06 Apr 2022
Cited by: 3 articles | PMID: 35397988
Add to export list
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
Basile D, Broudin C, Emile JF, Falcoz A, Pagès F, Mineur L, Bennouna J, Louvet C, Artru P, Fratte S, Ghiringhelli F, André T, Derangère V, Vernerey D, Taieb J, Svrcek M, for PRODIGE investigators, GERCOR, Fédération Française de Cancerologie Digestive, and UNICANCER
Ann Oncol, 33(6):628-637, 16 Mar 2022
Cited by: 12 articles | PMID: 35306156
Add to export list
Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studies.
Edeline J, Hirano S, Bertaut A, Konishi M, Benabdelghani M, Uesaka K, Watelet J, Ohtsuka M, Hammel P, Kaneoka Y, Joly JP, Yamamoto M, Monard L, Ambo Y, Louvet C, Ando M, Malka D, Nagino M, Phelip JM, Ebata T
Eur J Cancer, 164:80-87, 16 Feb 2022
Cited by: 10 articles | PMID: 35182925
Add to export list
Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus-Associated Gastric Adenocarcinoma With ERBB2 Amplification.
Watson S, Cyrta J, Lefevre M, Planchon JM, Louvet C, Servois V, Vaflard P, Bidard FC, Bieche I, Soularue E
JCO Precis Oncol, 5:370-377, 01 Nov 2021
Cited by: 0 articles | PMID: 34994599
Add to export list

1-25 of 312 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Partnerships & funding